The Circuit Court Split On 'Fraud On The FDA' Continues
On Feb. 22, 2012, the U.S. Court of Appeals for the Fifth Circuit unanimously affirmed the U.S. District Court for the Northern District of Texas' granting of a defendant drug manufacturer's...To view the full article, register now.
Already a subscriber? Click here to view full article